Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | MGAM | O43451 | 1/20 | 0.56 |
| ▸ | SI | P14410 | 1/20 | 0.56 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.56 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.50 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.40 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL6720383 | 1.00 | GAA (0.56) | GAAMGAMSIMGAM2CYP4F2 | |
| Acetic Acid SCHEMBL3462809 | 1.00 | GAA (0.56) | GAAMGAMSIMGAM2CYP4F2 | |
| Acetic Acid SCHEMBL3156541 | 1.00 | GAA (0.56) | GAAMGAMSIMGAM2CYP4F2 | |
| Acetic Acid SCHEMBL413364 | 1.00 | GAA (0.56) | GAAMGAMSIMGAM2CYP4F2 | |
| Acetic Acid SCHEMBL8521751 | 1.00 | GAA (0.56) | GAAMGAMSIMGAM2CYP4F2 | |
| Acetic Acid SCHEMBL146529 | 1.00 | GAA (0.56) | GAAMGAMSIMGAM2CYP4F2 | |
| Acetic Acid SCHEMBL370017 | 1.00 | GAA (0.56) | GAAMGAMSIMGAM2CYP4F2 | |
| Acetic Acid SCHEMBL787505 | 1.00 | GAA (0.56) | GAAMGAMSIMGAM2CYP4F2 | |
| Acetic Acid SCHEMBL1080927 | 1.00 | GAA (0.56) | GAAMGAMSIMGAM2CYP4F2 | |
| Acetic Acid SCHEMBL988151 | 1.00 | GAA (0.56) | GAAMGAMSIMGAM2CYP4F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6949567-B2 | Compounds for the treatment of protozoal diseases | 4SC AG (DE) | 2005-09-27 | — | — | US | disclosed |
| EP-1395548-A1 | DERIVATIVES OF DIPHENYLUREA, DIPHENYLOXALIC ACID DIAMIDE AND DIPHENYLSULFURIC ACID DIAMIDE AND THEIR USE AS MEDICAMENTS | 4SC AG (DE) | 2004-03-10 | — | — | EP | disclosed |
| US-20030119876-A1 | Compounds for the treatment of protozoal diseases | 4SC AG (DE) | 2003-06-26 | — | — | US | disclosed |
| CN-1099418-C | Tetrahydro-3-furanyl methylamine | MITSUI CHEMICALS INC (JP) | 2003-01-22 | — | — | CN | disclosed |
| US-20020165236-A1 | Compounds for the treatment of protozoal diseases | 4SC AG (DE) | 2002-11-07 | — | — | US | disclosed |
| WO-2002070467-A1 | DERIVATIVES OF DIPHENYLUREA, DIPHENYLOXALIC ACID DIAMIDE AND DIPHENYLSULFURIC ACID DIAMIDE AND THEIR USE AS MEDICAMENTS | 4SC AG (DE) | 2002-09-12 | — | — | WO | disclosed |
| CN-1046508-C | (tetrahydro-3-furanyl) methylamine derivatives, insecticides containing the same and intermediates thereof | MITSUI TOATSU CHEMICALS (JP) | 1999-11-17 | — | — | CN | disclosed |
| US-5977097-A | 1-methylcarbapenem derivatives | SANKYO COMPANY LIMITED (JP) | 1999-11-02 | — | — | US | disclosed |
| CN-1220991-A | Tetrahydro-3-furanyl methylamine | MITSUI CHEMICALS INC (JP) | 1999-06-30 | — | — | CN | disclosed |
| EP-0900797-A1 | 1-METHYLCARBAPENEM DERIVATIVES | SANKYO COMPANY LIMITED (JP) | 1999-03-10 | — | — | EP | disclosed |
| EP-0649845-B1 | Furanyl insecticide | MITSUI CHEMICALS INC (JP) | 1998-07-22 | — | — | EP | disclosed |
| US-5532365-A | NITROGUANIDINE COMPOUNDS AS INSECTICIDES | MITSUI TOATSU CHEMICALS, INC. (JP) | 1996-07-02 | — | — | US | disclosed |
| CN-1112556-A | Furanyl pesticide | MITSUI TOATSU CHEMICALS (JP) | 1995-11-29 | — | — | CN | disclosed |
| US-5434181-A | FOR USE IN AGRICULTURAL CHEMICALS | MITSUI TOATSU CHEMICALS, INC. (JP) | 1995-07-18 | — | — | US | disclosed |
| EP-0649845-A1 | Furanyl insecticide | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1995-04-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020165236-A1 | Compounds for the treatment of protozoal diseases | PKD2, PPOX, PKD1 | GAA 657/4885MGAM 1386/4885SI 1344/4885 |
| US-20030119876-A1 | Compounds for the treatment of protozoal diseases | CLIC1, PKD2, PKD1 | GAA 1194/4885MGAM 3663/4885SI 1658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.